|
Product complaint # (b)(4).Date sent to the fda: 10/09/2020.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.H3 evaluation: representative samples returned to support investigation of multiple device issues captured in reports 2210968-2020-06244, 2210968-2020-06245, 2210968-2020-06246, 2210968-2020-06247, 2210968-2020-06248, and 2210968-2020-06249.Analysis results have been included in follow-up reports for each.Two sealed boxes and unopened samples of product were received for evaluation.During the visual inspection of unopened samples, no defects were found on the packages.The samples were opened, and the swage and attachment area were noted to be as expected.The sutures were dispensed without problems and examined along the strand with no defects, damage or suture breakage noted.A functional test was performed and the tensile strength force was above the minimum requirement.As part of our quality process, the manufacturing records of this lot-serial number were reviewed, and the manufacturing standards were met prior to the release of this batch.The device is visually inspected and functionally tested during manufacturing to ensure the device meets the required specifications prior to shipment.The device performed without any defect noted and the actual complaint sample was not returned for analysis.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc., or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|